Viewray (NASDAQ:VRAY) issued its quarterly earnings results on Monday, March 12th. The company reported ($0.38) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.25) by ($0.13), Briefing.com reports. The business had revenue of $19.90 million during the quarter, compared to the consensus estimate of $21.23 million. The company’s quarterly revenue was up 23.6% on a year-over-year basis.
Viewray stock traded up $0.10 during mid-day trading on Thursday, hitting $6.54. The company’s stock had a trading volume of 366,109 shares, compared to its average volume of 660,662. The firm has a market capitalization of $451.27, a price-to-earnings ratio of -6.29 and a beta of 0.63. Viewray has a 1 year low of $4.40 and a 1 year high of $10.64. The company has a debt-to-equity ratio of 22.47, a quick ratio of 1.84 and a current ratio of 2.18.
A number of equities analysts have commented on VRAY shares. BidaskClub raised Viewray from a “hold” rating to a “buy” rating in a report on Friday, December 22nd. Mizuho reissued a “buy” rating and set a $12.00 target price on shares of Viewray in a report on Tuesday, January 9th. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Viewray in a report on Friday, January 5th. Finally, B. Riley initiated coverage on Viewray in a report on Thursday, February 8th. They issued a “buy” rating and a $13.50 price target for the company. Two research analysts have rated the stock with a sell rating and six have issued a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus price target of $11.58.
Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. MetLife Investment Advisors LLC purchased a new position in shares of Viewray during the fourth quarter worth $148,000. Park West Asset Management LLC purchased a new position in shares of Viewray during the fourth quarter worth $24,217,000. PEAK6 Investments L.P. purchased a new position in Viewray in the fourth quarter valued at $148,000. Perceptive Advisors LLC purchased a new position in Viewray in the fourth quarter valued at $463,000. Finally, Deutsche Bank AG boosted its holdings in Viewray by 137.6% in the fourth quarter. Deutsche Bank AG now owns 67,190 shares of the company’s stock valued at $622,000 after purchasing an additional 38,913 shares during the period. Institutional investors and hedge funds own 80.80% of the company’s stock.
TRADEMARK VIOLATION WARNING: This piece was first published by BBNS and is the property of of BBNS. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this piece can be accessed at https://baseballnewssource.com/2018/04/05/viewray-vray-releases-earnings-results-misses-estimates-by-0-13-eps/2028070.html.
Viewray Company Profile
ViewRay, Inc designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company’s software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered.
Receive News & Ratings for Viewray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viewray and related companies with MarketBeat.com's FREE daily email newsletter.